Indefinite Delivery Contract SPE2DR25D2012

The Indefinite Delivery Contract (IDC) SPE2DR25D2012 is a $999,999,999 single-award contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The IDC serves as a primary vehicle for DLA Troop Support to procure critical medical commodities across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. The contract has a base period of 30 months and three 30-month option periods, running through December 2036.

The IDC was established through a pre-solicitation (Opportunity ID: bae3e46b4e4c421385f0d20aaf2c4525) for the DLA Troop Support Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract. This unrestricted, fully competitive acquisition aims to award multiple primary supplier contracts, as well as a separate back-up supplier contract, to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The estimated total value for all regions and options is $30.3 billion.